Skip to main content
. 2016 May 6;7(23):35313–35326. doi: 10.18632/oncotarget.9204

Figure 3.

Figure 3

EGCG treatment increases A. RXRα protein levels, attenuates nuclear β-catenin levels and cyclin D1 protein levels, and B. increase cytosolic phospho-β-catenin and β-catenin in CIMP+ lines (HCT116, SW48), while a modest changes was observed (HT29) and little change in the CIMP- cell line (SW480). Total of 50 μg of nuclear and cytosolic protein was used in each blot.